nodes	percent_of_prediction	percent_of_DWPC	metapath
Desloratadine—CYP2C19—Ifosfamide—testicular cancer	0.13	0.174	CbGbCtD
Desloratadine—CYP2C9—Ifosfamide—testicular cancer	0.108	0.145	CbGbCtD
Desloratadine—ABCB1—Dactinomycin—testicular cancer	0.0885	0.119	CbGbCtD
Desloratadine—CYP1A2—Etoposide—testicular cancer	0.0571	0.0769	CbGbCtD
Desloratadine—ABCB1—Vinblastine—testicular cancer	0.0555	0.0746	CbGbCtD
Desloratadine—CYP2C9—Cisplatin—testicular cancer	0.0524	0.0705	CbGbCtD
Desloratadine—CYP2D6—Vinblastine—testicular cancer	0.0522	0.0703	CbGbCtD
Desloratadine—ABCB1—Cisplatin—testicular cancer	0.0508	0.0684	CbGbCtD
Desloratadine—ABCB1—Etoposide—testicular cancer	0.05	0.0672	CbGbCtD
Desloratadine—ABCB1—Doxorubicin—testicular cancer	0.0341	0.0459	CbGbCtD
Desloratadine—ABCB1—Methotrexate—testicular cancer	0.033	0.0444	CbGbCtD
Desloratadine—CYP2D6—Doxorubicin—testicular cancer	0.0321	0.0432	CbGbCtD
Desloratadine—Myalgia—Ifosfamide—testicular cancer	0.000883	0.00344	CcSEcCtD
Desloratadine—Anorexia—Dactinomycin—testicular cancer	0.000881	0.00343	CcSEcCtD
Desloratadine—Diarrhoea—Chlorambucil—testicular cancer	0.000876	0.00341	CcSEcCtD
Desloratadine—Cardiac disorder—Etoposide—testicular cancer	0.000874	0.0034	CcSEcCtD
Desloratadine—Hypersensitivity—Vinblastine—testicular cancer	0.000864	0.00336	CcSEcCtD
Desloratadine—Decreased appetite—Bleomycin—testicular cancer	0.000861	0.00335	CcSEcCtD
Desloratadine—Anaphylactic shock—Ifosfamide—testicular cancer	0.000847	0.0033	CcSEcCtD
Desloratadine—Oedema—Ifosfamide—testicular cancer	0.000847	0.0033	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000842	0.00328	CcSEcCtD
Desloratadine—Asthenia—Vinblastine—testicular cancer	0.000842	0.00328	CcSEcCtD
Desloratadine—Infection—Ifosfamide—testicular cancer	0.000841	0.00327	CcSEcCtD
Desloratadine—Nervous system disorder—Ifosfamide—testicular cancer	0.00083	0.00323	CcSEcCtD
Desloratadine—Vomiting—Chlorambucil—testicular cancer	0.000814	0.00317	CcSEcCtD
Desloratadine—Increased appetite—Epirubicin—testicular cancer	0.000812	0.00316	CcSEcCtD
Desloratadine—Anorexia—Ifosfamide—testicular cancer	0.000807	0.00314	CcSEcCtD
Desloratadine—Decreased appetite—Dactinomycin—testicular cancer	0.000803	0.00313	CcSEcCtD
Desloratadine—Diarrhoea—Vinblastine—testicular cancer	0.000803	0.00312	CcSEcCtD
Desloratadine—Fatigue—Dactinomycin—testicular cancer	0.000797	0.0031	CcSEcCtD
Desloratadine—Urticaria—Bleomycin—testicular cancer	0.000787	0.00306	CcSEcCtD
Desloratadine—Body temperature increased—Bleomycin—testicular cancer	0.000783	0.00305	CcSEcCtD
Desloratadine—Irritability—Methotrexate—testicular cancer	0.000778	0.00303	CcSEcCtD
Desloratadine—Dizziness—Vinblastine—testicular cancer	0.000776	0.00302	CcSEcCtD
Desloratadine—Convulsion—Cisplatin—testicular cancer	0.000775	0.00302	CcSEcCtD
Desloratadine—Mood swings—Methotrexate—testicular cancer	0.000772	0.003	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000771	0.003	CcSEcCtD
Desloratadine—Myalgia—Cisplatin—testicular cancer	0.000762	0.00296	CcSEcCtD
Desloratadine—Nausea—Chlorambucil—testicular cancer	0.00076	0.00296	CcSEcCtD
Desloratadine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000756	0.00294	CcSEcCtD
Desloratadine—Dyspnoea—Ifosfamide—testicular cancer	0.000755	0.00294	CcSEcCtD
Desloratadine—Somnolence—Ifosfamide—testicular cancer	0.000753	0.00293	CcSEcCtD
Desloratadine—Increased appetite—Doxorubicin—testicular cancer	0.000751	0.00292	CcSEcCtD
Desloratadine—Affect lability—Epirubicin—testicular cancer	0.000751	0.00292	CcSEcCtD
Desloratadine—Vomiting—Vinblastine—testicular cancer	0.000746	0.0029	CcSEcCtD
Desloratadine—Breast disorder—Methotrexate—testicular cancer	0.000737	0.00287	CcSEcCtD
Desloratadine—Decreased appetite—Ifosfamide—testicular cancer	0.000736	0.00286	CcSEcCtD
Desloratadine—Headache—Vinblastine—testicular cancer	0.000735	0.00286	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000731	0.00284	CcSEcCtD
Desloratadine—Abdominal pain—Dactinomycin—testicular cancer	0.00073	0.00284	CcSEcCtD
Desloratadine—Body temperature increased—Dactinomycin—testicular cancer	0.00073	0.00284	CcSEcCtD
Desloratadine—Fatigue—Ifosfamide—testicular cancer	0.00073	0.00284	CcSEcCtD
Desloratadine—Anaphylactic shock—Cisplatin—testicular cancer	0.00073	0.00284	CcSEcCtD
Desloratadine—Oedema—Cisplatin—testicular cancer	0.00073	0.00284	CcSEcCtD
Desloratadine—Hypersensitivity—Bleomycin—testicular cancer	0.00073	0.00284	CcSEcCtD
Desloratadine—Infection—Cisplatin—testicular cancer	0.000725	0.00282	CcSEcCtD
Desloratadine—Mood swings—Epirubicin—testicular cancer	0.000723	0.00281	CcSEcCtD
Desloratadine—Nervous system disorder—Cisplatin—testicular cancer	0.000716	0.00279	CcSEcCtD
Desloratadine—Cough—Etoposide—testicular cancer	0.000715	0.00278	CcSEcCtD
Desloratadine—Tachycardia—Cisplatin—testicular cancer	0.000712	0.00277	CcSEcCtD
Desloratadine—Asthenia—Bleomycin—testicular cancer	0.000711	0.00277	CcSEcCtD
Desloratadine—Convulsion—Etoposide—testicular cancer	0.00071	0.00276	CcSEcCtD
Desloratadine—Pruritus—Bleomycin—testicular cancer	0.000701	0.00273	CcSEcCtD
Desloratadine—Nausea—Vinblastine—testicular cancer	0.000697	0.00271	CcSEcCtD
Desloratadine—Anorexia—Cisplatin—testicular cancer	0.000696	0.00271	CcSEcCtD
Desloratadine—Affect lability—Doxorubicin—testicular cancer	0.000695	0.0027	CcSEcCtD
Desloratadine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000692	0.00269	CcSEcCtD
Desloratadine—Breast disorder—Epirubicin—testicular cancer	0.000689	0.00268	CcSEcCtD
Desloratadine—Nasopharyngitis—Epirubicin—testicular cancer	0.000682	0.00265	CcSEcCtD
Desloratadine—Hypersensitivity—Dactinomycin—testicular cancer	0.000681	0.00265	CcSEcCtD
Desloratadine—Urticaria—Ifosfamide—testicular cancer	0.000673	0.00262	CcSEcCtD
Desloratadine—Abdominal pain—Ifosfamide—testicular cancer	0.000669	0.00261	CcSEcCtD
Desloratadine—Body temperature increased—Ifosfamide—testicular cancer	0.000669	0.00261	CcSEcCtD
Desloratadine—Anaphylactic shock—Etoposide—testicular cancer	0.000669	0.0026	CcSEcCtD
Desloratadine—Mood swings—Doxorubicin—testicular cancer	0.000669	0.0026	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000665	0.00259	CcSEcCtD
Desloratadine—Infection—Etoposide—testicular cancer	0.000664	0.00259	CcSEcCtD
Desloratadine—Asthenia—Dactinomycin—testicular cancer	0.000663	0.00258	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000655	0.00255	CcSEcCtD
Desloratadine—Tachycardia—Etoposide—testicular cancer	0.000653	0.00254	CcSEcCtD
Desloratadine—Dyspnoea—Cisplatin—testicular cancer	0.000651	0.00253	CcSEcCtD
Desloratadine—Breast disorder—Doxorubicin—testicular cancer	0.000638	0.00248	CcSEcCtD
Desloratadine—Anorexia—Etoposide—testicular cancer	0.000637	0.00248	CcSEcCtD
Desloratadine—Decreased appetite—Cisplatin—testicular cancer	0.000635	0.00247	CcSEcCtD
Desloratadine—Bronchitis—Epirubicin—testicular cancer	0.000634	0.00247	CcSEcCtD
Desloratadine—Diarrhoea—Dactinomycin—testicular cancer	0.000632	0.00246	CcSEcCtD
Desloratadine—Nasopharyngitis—Doxorubicin—testicular cancer	0.000631	0.00246	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00063	0.00245	CcSEcCtD
Desloratadine—Vomiting—Bleomycin—testicular cancer	0.00063	0.00245	CcSEcCtD
Desloratadine—Infestation NOS—Methotrexate—testicular cancer	0.000628	0.00244	CcSEcCtD
Desloratadine—Infestation—Methotrexate—testicular cancer	0.000628	0.00244	CcSEcCtD
Desloratadine—Rash—Bleomycin—testicular cancer	0.000625	0.00243	CcSEcCtD
Desloratadine—Dermatitis—Bleomycin—testicular cancer	0.000624	0.00243	CcSEcCtD
Desloratadine—Hypersensitivity—Ifosfamide—testicular cancer	0.000624	0.00243	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000613	0.00238	CcSEcCtD
Desloratadine—Asthenia—Ifosfamide—testicular cancer	0.000608	0.00236	CcSEcCtD
Desloratadine—Pruritus—Ifosfamide—testicular cancer	0.000599	0.00233	CcSEcCtD
Desloratadine—Dyspnoea—Etoposide—testicular cancer	0.000596	0.00232	CcSEcCtD
Desloratadine—Somnolence—Etoposide—testicular cancer	0.000595	0.00231	CcSEcCtD
Desloratadine—Hepatobiliary disease—Methotrexate—testicular cancer	0.000594	0.00231	CcSEcCtD
Desloratadine—Epistaxis—Methotrexate—testicular cancer	0.000592	0.00231	CcSEcCtD
Desloratadine—Nausea—Bleomycin—testicular cancer	0.000589	0.00229	CcSEcCtD
Desloratadine—Infestation NOS—Epirubicin—testicular cancer	0.000588	0.00229	CcSEcCtD
Desloratadine—Infestation—Epirubicin—testicular cancer	0.000588	0.00229	CcSEcCtD
Desloratadine—Vomiting—Dactinomycin—testicular cancer	0.000588	0.00229	CcSEcCtD
Desloratadine—Bronchitis—Doxorubicin—testicular cancer	0.000587	0.00228	CcSEcCtD
Desloratadine—Rash—Dactinomycin—testicular cancer	0.000583	0.00227	CcSEcCtD
Desloratadine—Decreased appetite—Etoposide—testicular cancer	0.000581	0.00226	CcSEcCtD
Desloratadine—Diarrhoea—Ifosfamide—testicular cancer	0.000579	0.00225	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Etoposide—testicular cancer	0.000577	0.00225	CcSEcCtD
Desloratadine—Body temperature increased—Cisplatin—testicular cancer	0.000577	0.00225	CcSEcCtD
Desloratadine—Fatigue—Etoposide—testicular cancer	0.000577	0.00224	CcSEcCtD
Desloratadine—Urinary tract infection—Epirubicin—testicular cancer	0.000571	0.00222	CcSEcCtD
Desloratadine—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000567	0.00221	CcSEcCtD
Desloratadine—Hepatitis—Methotrexate—testicular cancer	0.000564	0.00219	CcSEcCtD
Desloratadine—Dizziness—Ifosfamide—testicular cancer	0.00056	0.00218	CcSEcCtD
Desloratadine—Pharyngitis—Methotrexate—testicular cancer	0.00056	0.00218	CcSEcCtD
Desloratadine—Hepatobiliary disease—Epirubicin—testicular cancer	0.000556	0.00216	CcSEcCtD
Desloratadine—Epistaxis—Epirubicin—testicular cancer	0.000554	0.00216	CcSEcCtD
Desloratadine—Nausea—Dactinomycin—testicular cancer	0.000549	0.00214	CcSEcCtD
Desloratadine—Gastrointestinal pain—Etoposide—testicular cancer	0.000547	0.00213	CcSEcCtD
Desloratadine—Infestation NOS—Doxorubicin—testicular cancer	0.000544	0.00212	CcSEcCtD
Desloratadine—Infestation—Doxorubicin—testicular cancer	0.000544	0.00212	CcSEcCtD
Desloratadine—Vomiting—Ifosfamide—testicular cancer	0.000538	0.0021	CcSEcCtD
Desloratadine—Hypersensitivity—Cisplatin—testicular cancer	0.000538	0.00209	CcSEcCtD
Desloratadine—Rash—Ifosfamide—testicular cancer	0.000534	0.00208	CcSEcCtD
Desloratadine—Dermatitis—Ifosfamide—testicular cancer	0.000533	0.00208	CcSEcCtD
Desloratadine—Urticaria—Etoposide—testicular cancer	0.000531	0.00207	CcSEcCtD
Desloratadine—Body temperature increased—Etoposide—testicular cancer	0.000529	0.00206	CcSEcCtD
Desloratadine—Abdominal pain—Etoposide—testicular cancer	0.000529	0.00206	CcSEcCtD
Desloratadine—Urinary tract infection—Doxorubicin—testicular cancer	0.000529	0.00206	CcSEcCtD
Desloratadine—Hepatitis—Epirubicin—testicular cancer	0.000528	0.00205	CcSEcCtD
Desloratadine—Asthenia—Cisplatin—testicular cancer	0.000524	0.00204	CcSEcCtD
Desloratadine—Pharyngitis—Epirubicin—testicular cancer	0.000524	0.00204	CcSEcCtD
Desloratadine—Cardiac disorder—Methotrexate—testicular cancer	0.000523	0.00204	CcSEcCtD
Desloratadine—Connective tissue disorder—Epirubicin—testicular cancer	0.000519	0.00202	CcSEcCtD
Desloratadine—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000514	0.002	CcSEcCtD
Desloratadine—Epistaxis—Doxorubicin—testicular cancer	0.000513	0.002	CcSEcCtD
Desloratadine—Nausea—Ifosfamide—testicular cancer	0.000503	0.00196	CcSEcCtD
Desloratadine—Diarrhoea—Cisplatin—testicular cancer	0.000499	0.00194	CcSEcCtD
Desloratadine—Mental disorder—Methotrexate—testicular cancer	0.000494	0.00192	CcSEcCtD
Desloratadine—Hypersensitivity—Etoposide—testicular cancer	0.000493	0.00192	CcSEcCtD
Desloratadine—Erythema—Methotrexate—testicular cancer	0.000491	0.00191	CcSEcCtD
Desloratadine—Cardiac disorder—Epirubicin—testicular cancer	0.00049	0.00191	CcSEcCtD
Desloratadine—Hepatitis—Doxorubicin—testicular cancer	0.000488	0.0019	CcSEcCtD
Desloratadine—Pharyngitis—Doxorubicin—testicular cancer	0.000485	0.00189	CcSEcCtD
Desloratadine—Asthenia—Etoposide—testicular cancer	0.00048	0.00187	CcSEcCtD
Desloratadine—Connective tissue disorder—Doxorubicin—testicular cancer	0.00048	0.00187	CcSEcCtD
Desloratadine—Pruritus—Etoposide—testicular cancer	0.000473	0.00184	CcSEcCtD
Desloratadine—Vomiting—Cisplatin—testicular cancer	0.000464	0.00181	CcSEcCtD
Desloratadine—Mental disorder—Epirubicin—testicular cancer	0.000462	0.0018	CcSEcCtD
Desloratadine—Rash—Cisplatin—testicular cancer	0.00046	0.00179	CcSEcCtD
Desloratadine—Dermatitis—Cisplatin—testicular cancer	0.00046	0.00179	CcSEcCtD
Desloratadine—Erythema—Epirubicin—testicular cancer	0.000459	0.00179	CcSEcCtD
Desloratadine—Diarrhoea—Etoposide—testicular cancer	0.000458	0.00178	CcSEcCtD
Desloratadine—Cardiac disorder—Doxorubicin—testicular cancer	0.000453	0.00176	CcSEcCtD
Desloratadine—Dizziness—Etoposide—testicular cancer	0.000442	0.00172	CcSEcCtD
Desloratadine—Nausea—Cisplatin—testicular cancer	0.000434	0.00169	CcSEcCtD
Desloratadine—Cough—Methotrexate—testicular cancer	0.000428	0.00167	CcSEcCtD
Desloratadine—Mental disorder—Doxorubicin—testicular cancer	0.000428	0.00166	CcSEcCtD
Desloratadine—Convulsion—Methotrexate—testicular cancer	0.000425	0.00166	CcSEcCtD
Desloratadine—Vomiting—Etoposide—testicular cancer	0.000425	0.00165	CcSEcCtD
Desloratadine—Erythema—Doxorubicin—testicular cancer	0.000425	0.00165	CcSEcCtD
Desloratadine—Agitation—Epirubicin—testicular cancer	0.000422	0.00164	CcSEcCtD
Desloratadine—Rash—Etoposide—testicular cancer	0.000422	0.00164	CcSEcCtD
Desloratadine—Dermatitis—Etoposide—testicular cancer	0.000421	0.00164	CcSEcCtD
Desloratadine—Headache—Etoposide—testicular cancer	0.000419	0.00163	CcSEcCtD
Desloratadine—Myalgia—Methotrexate—testicular cancer	0.000418	0.00163	CcSEcCtD
Desloratadine—Palpitations—Epirubicin—testicular cancer	0.000406	0.00158	CcSEcCtD
Desloratadine—Cough—Epirubicin—testicular cancer	0.000401	0.00156	CcSEcCtD
Desloratadine—Anaphylactic shock—Methotrexate—testicular cancer	0.000401	0.00156	CcSEcCtD
Desloratadine—Convulsion—Epirubicin—testicular cancer	0.000398	0.00155	CcSEcCtD
Desloratadine—Infection—Methotrexate—testicular cancer	0.000398	0.00155	CcSEcCtD
Desloratadine—Nausea—Etoposide—testicular cancer	0.000397	0.00155	CcSEcCtD
Desloratadine—Nervous system disorder—Methotrexate—testicular cancer	0.000393	0.00153	CcSEcCtD
Desloratadine—Myalgia—Epirubicin—testicular cancer	0.000391	0.00152	CcSEcCtD
Desloratadine—Agitation—Doxorubicin—testicular cancer	0.000391	0.00152	CcSEcCtD
Desloratadine—Dry mouth—Epirubicin—testicular cancer	0.000382	0.00149	CcSEcCtD
Desloratadine—Anorexia—Methotrexate—testicular cancer	0.000382	0.00149	CcSEcCtD
Desloratadine—Palpitations—Doxorubicin—testicular cancer	0.000376	0.00146	CcSEcCtD
Desloratadine—Anaphylactic shock—Epirubicin—testicular cancer	0.000375	0.00146	CcSEcCtD
Desloratadine—Oedema—Epirubicin—testicular cancer	0.000375	0.00146	CcSEcCtD
Desloratadine—Infection—Epirubicin—testicular cancer	0.000372	0.00145	CcSEcCtD
Desloratadine—Cough—Doxorubicin—testicular cancer	0.000371	0.00144	CcSEcCtD
Desloratadine—Convulsion—Doxorubicin—testicular cancer	0.000368	0.00143	CcSEcCtD
Desloratadine—Nervous system disorder—Epirubicin—testicular cancer	0.000368	0.00143	CcSEcCtD
Desloratadine—Tachycardia—Epirubicin—testicular cancer	0.000366	0.00142	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000365	0.00142	CcSEcCtD
Desloratadine—Insomnia—Methotrexate—testicular cancer	0.000362	0.00141	CcSEcCtD
Desloratadine—Myalgia—Doxorubicin—testicular cancer	0.000362	0.00141	CcSEcCtD
Desloratadine—Anorexia—Epirubicin—testicular cancer	0.000357	0.00139	CcSEcCtD
Desloratadine—Dyspnoea—Methotrexate—testicular cancer	0.000357	0.00139	CcSEcCtD
Desloratadine—Somnolence—Methotrexate—testicular cancer	0.000356	0.00139	CcSEcCtD
Desloratadine—Dry mouth—Doxorubicin—testicular cancer	0.000354	0.00138	CcSEcCtD
Desloratadine—Dyspepsia—Methotrexate—testicular cancer	0.000353	0.00137	CcSEcCtD
Desloratadine—Decreased appetite—Methotrexate—testicular cancer	0.000348	0.00136	CcSEcCtD
Desloratadine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000347	0.00135	CcSEcCtD
Desloratadine—Oedema—Doxorubicin—testicular cancer	0.000347	0.00135	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000346	0.00135	CcSEcCtD
Desloratadine—Fatigue—Methotrexate—testicular cancer	0.000345	0.00134	CcSEcCtD
Desloratadine—Infection—Doxorubicin—testicular cancer	0.000345	0.00134	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000342	0.00133	CcSEcCtD
Desloratadine—Nervous system disorder—Doxorubicin—testicular cancer	0.00034	0.00132	CcSEcCtD
Desloratadine—Insomnia—Epirubicin—testicular cancer	0.000339	0.00132	CcSEcCtD
Desloratadine—Tachycardia—Doxorubicin—testicular cancer	0.000339	0.00132	CcSEcCtD
Desloratadine—Dyspnoea—Epirubicin—testicular cancer	0.000334	0.0013	CcSEcCtD
Desloratadine—Somnolence—Epirubicin—testicular cancer	0.000333	0.0013	CcSEcCtD
Desloratadine—Anorexia—Doxorubicin—testicular cancer	0.000331	0.00129	CcSEcCtD
Desloratadine—Dyspepsia—Epirubicin—testicular cancer	0.00033	0.00128	CcSEcCtD
Desloratadine—Gastrointestinal pain—Methotrexate—testicular cancer	0.000328	0.00127	CcSEcCtD
Desloratadine—Decreased appetite—Epirubicin—testicular cancer	0.000326	0.00127	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000324	0.00126	CcSEcCtD
Desloratadine—Fatigue—Epirubicin—testicular cancer	0.000323	0.00126	CcSEcCtD
Desloratadine—Urticaria—Methotrexate—testicular cancer	0.000318	0.00124	CcSEcCtD
Desloratadine—Body temperature increased—Methotrexate—testicular cancer	0.000317	0.00123	CcSEcCtD
Desloratadine—Abdominal pain—Methotrexate—testicular cancer	0.000317	0.00123	CcSEcCtD
Desloratadine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000316	0.00123	CcSEcCtD
Desloratadine—Insomnia—Doxorubicin—testicular cancer	0.000314	0.00122	CcSEcCtD
Desloratadine—Dyspnoea—Doxorubicin—testicular cancer	0.000309	0.0012	CcSEcCtD
Desloratadine—Somnolence—Doxorubicin—testicular cancer	0.000308	0.0012	CcSEcCtD
Desloratadine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000307	0.00119	CcSEcCtD
Desloratadine—Dyspepsia—Doxorubicin—testicular cancer	0.000305	0.00119	CcSEcCtD
Desloratadine—Decreased appetite—Doxorubicin—testicular cancer	0.000302	0.00117	CcSEcCtD
Desloratadine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000299	0.00117	CcSEcCtD
Desloratadine—Fatigue—Doxorubicin—testicular cancer	0.000299	0.00116	CcSEcCtD
Desloratadine—Urticaria—Epirubicin—testicular cancer	0.000298	0.00116	CcSEcCtD
Desloratadine—Body temperature increased—Epirubicin—testicular cancer	0.000296	0.00115	CcSEcCtD
Desloratadine—Abdominal pain—Epirubicin—testicular cancer	0.000296	0.00115	CcSEcCtD
Desloratadine—Hypersensitivity—Methotrexate—testicular cancer	0.000295	0.00115	CcSEcCtD
Desloratadine—Asthenia—Methotrexate—testicular cancer	0.000287	0.00112	CcSEcCtD
Desloratadine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000284	0.0011	CcSEcCtD
Desloratadine—Pruritus—Methotrexate—testicular cancer	0.000283	0.0011	CcSEcCtD
Desloratadine—Hypersensitivity—Epirubicin—testicular cancer	0.000276	0.00107	CcSEcCtD
Desloratadine—Urticaria—Doxorubicin—testicular cancer	0.000276	0.00107	CcSEcCtD
Desloratadine—Abdominal pain—Doxorubicin—testicular cancer	0.000274	0.00107	CcSEcCtD
Desloratadine—Body temperature increased—Doxorubicin—testicular cancer	0.000274	0.00107	CcSEcCtD
Desloratadine—Diarrhoea—Methotrexate—testicular cancer	0.000274	0.00107	CcSEcCtD
Desloratadine—Asthenia—Epirubicin—testicular cancer	0.000269	0.00105	CcSEcCtD
Desloratadine—Pruritus—Epirubicin—testicular cancer	0.000265	0.00103	CcSEcCtD
Desloratadine—Dizziness—Methotrexate—testicular cancer	0.000265	0.00103	CcSEcCtD
Desloratadine—Diarrhoea—Epirubicin—testicular cancer	0.000256	0.000998	CcSEcCtD
Desloratadine—Hypersensitivity—Doxorubicin—testicular cancer	0.000256	0.000995	CcSEcCtD
Desloratadine—Vomiting—Methotrexate—testicular cancer	0.000255	0.000991	CcSEcCtD
Desloratadine—Rash—Methotrexate—testicular cancer	0.000253	0.000983	CcSEcCtD
Desloratadine—Dermatitis—Methotrexate—testicular cancer	0.000252	0.000982	CcSEcCtD
Desloratadine—Headache—Methotrexate—testicular cancer	0.000251	0.000977	CcSEcCtD
Desloratadine—Asthenia—Doxorubicin—testicular cancer	0.000249	0.000969	CcSEcCtD
Desloratadine—Dizziness—Epirubicin—testicular cancer	0.000248	0.000965	CcSEcCtD
Desloratadine—Pruritus—Doxorubicin—testicular cancer	0.000245	0.000955	CcSEcCtD
Desloratadine—Vomiting—Epirubicin—testicular cancer	0.000238	0.000928	CcSEcCtD
Desloratadine—Nausea—Methotrexate—testicular cancer	0.000238	0.000926	CcSEcCtD
Desloratadine—Diarrhoea—Doxorubicin—testicular cancer	0.000237	0.000924	CcSEcCtD
Desloratadine—Rash—Epirubicin—testicular cancer	0.000236	0.00092	CcSEcCtD
Desloratadine—Dermatitis—Epirubicin—testicular cancer	0.000236	0.000919	CcSEcCtD
Desloratadine—Headache—Epirubicin—testicular cancer	0.000235	0.000914	CcSEcCtD
Desloratadine—Dizziness—Doxorubicin—testicular cancer	0.000229	0.000893	CcSEcCtD
Desloratadine—Nausea—Epirubicin—testicular cancer	0.000223	0.000867	CcSEcCtD
Desloratadine—Vomiting—Doxorubicin—testicular cancer	0.000221	0.000858	CcSEcCtD
Desloratadine—Rash—Doxorubicin—testicular cancer	0.000219	0.000851	CcSEcCtD
Desloratadine—Dermatitis—Doxorubicin—testicular cancer	0.000219	0.00085	CcSEcCtD
Desloratadine—Headache—Doxorubicin—testicular cancer	0.000217	0.000846	CcSEcCtD
Desloratadine—Nausea—Doxorubicin—testicular cancer	0.000206	0.000802	CcSEcCtD
